ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Advocacy Update 2025, Federal & State

Mary Beth Nierengarten  |  November 9, 2025

Among other priorities, McDaniel discussed the ongoing efforts to continue advocating for Medicare reimbursement. She said it is unfortunate the physician fee schedule is the only Medicare fee schedule not linked to inflation, and that the ACR is trying constantly to rectify that. She said progress is slow but the ACR is working on a bill, and she is hopeful some progress will be made on this in 2026. Specifically, the ACR seeks to increase reimbursement through the physician fee schedule by repealing sequestration cuts, repealing the balanced budget requirement and updating the physician fee schedule annually for inflation per the MEI.

McDaniel also discussed advocacy efforts to protect the 2021 evaluation and management (E/M) payment updates and recognition of the values of these services through frequent evaluations. In addition, the ACR is working with a medical specialty coalition and majority party Doctor’s Caucus on introducing legislation in 2026 to secure appropriate Medicare reimbursement and actually raise reimbursement rates, which have declined since 2020.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Another priority: vaccine access. Given clear signs of a government shift toward limiting vaccine access and away from science-based vaccine policy, McDaniel said the ACR has written a new policy statement explicitly stating the ACR supports vaccines for school-age children and immunocompromised patients and their close contacts. The policy statement also explicitly states the ACR supports payers covering the costs of vaccine access for these groups. In an earlier statement this year, the ACR stated the American public can have confidence in vaccines. The ACR has also communicated with Department of Health and Human Services Secretary Robert F. Kennedy, and urged the Senate Finance committee to pose questions about the state of the Centers for Disease Control and Prevention (CDC) during Secretary Kennedy’s testimony.

State Policy Updates

Joseph Cantrell, JD, director of State Affairs and Community Relations for the ACR, discussed advocacy for the same issues at the state level. He first noted the large amount of anti-vaccination legislation seen in state governments this legislative session. Currently, he said, 20 states propose to reduce the uptake of the vaccines by expanding non-medical exceptions or implementing “safety warnings” based on non-scientific data. Last year, the ACR saw anti-vaccine legislation in just four states. In one big win on this front, the ACR joined with the Arthritis Foundation to challenge a Florida proposal to eliminate vaccine requirements for children in public schools. That policy has been walked back because of the combined efforts of patient and provider groups.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceFrom the College Tagged with:ACR Convergence 2025AdvocacyCongressLegislation & AdvocacyMedicaidMedicare ReimbursementPhysician fee scheduletelehealthvaccine

Related Articles

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Space & Other Races

    October 19, 2020

    On April 5, 1950, a small group of scientists met in Silver Spring, Md., to talk about geophysics. I know this is not the most riveting way to start, but if you stick with me, I promise the story will get much more interesting. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEThis group of scientists met to discuss…

    ACR Convergence 2020

    ACR Convergence 2020: Progress Toward COVID-19 Vaccines

    November 11, 2020

    ACR CONVERGENCE 2020—A scientific session on Sunday, Nov. 8, focused on vaccine prospects in COVID-19. Dan Barouch, MD, PhD, director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center and the William Bosworth Castle Professor of Medicine at Harvard Medical School in Boston, shared his insights about vaccine development across…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences